CHYMORAL AP (Aceclofenac (100mg) + Paracetamol (325mg) + Trypsin Chymotrypsin (50000Au))
-15%

CHYMORAL AP (Aceclofenac (100mg) + Paracetamol (325mg) + Trypsin Chymotrypsin (50000Au))

Original price was: ₹179.30.Current price is: ₹152.96.

CHYMORAL AP (Aceclofenac (100mg) + Paracetamol (325mg) + Trypsin Chymotrypsin (50000Au))

Original price was: ₹179.30.Current price is: ₹152.96.

Add to cart
Buy Now
Category: Tag:

CHYMORAL AP TAB is a combination medication often used to help manage discomfort and pain associated with various conditions, such as inflammation or muscle injuries. It may support patients by providing relief from pain and reducing inflammation, helping them return to their daily activities more comfortably.

The active ingredients in CHYMORAL AP TAB work together to achieve this relief. Aceclofenac is a non-steroidal anti-inflammatory drug (NSAID) that helps decrease inflammation and alleviate pain. Paracetamol provides additional pain relief and helps lower fever, while Trypsin Chymotrypsin are enzymes that may promote healing by breaking down proteins that can delay recovery from injuries or surgeries.

When using this medication, it is advisable to store it in a cool, dry place away from direct sunlight. Consistency in usage is important for optimal benefits, so following the directions on the package is recommended. As with any medication, it’s essential to discuss your health conditions and any other medications you’re taking with your healthcare provider before use.

Some common side effects may include mild stomach upset, nausea, or dizziness. These effects are typically temporary but should be monitored. If they persist or worsen, consulting a healthcare professional is advised.

This is general information, not a substitute for medical advice. Always consult a doctor/pharmacist and read the package leaflet.

Reviews

There are no reviews yet.

Be the first to review “CHYMORAL AP (Aceclofenac (100mg) + Paracetamol (325mg) + Trypsin Chymotrypsin (50000Au))”

Your email address will not be published. Required fields are marked *

Top